Spots Global Cancer Trial Database for Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
Official Title: Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp
Study ID: NCT00581425
Conditions
Interventions
Study Description
Brief Summary: A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Texas Health Science Center of Houston Dermatology Clinic, Houston, Texas, United States
Contact Details
Name: Stephen B Tucker, M.D.
Affiliation: University of Texas Health Science Center of Houston Dermatology Clinic
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
